aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease

IŞIK A. T., Bozoglu E., Eker D.

JOURNAL OF NUTRITION HEALTH & AGING, vol.16, no.2, pp.139-141, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 2
  • Publication Date: 2012
  • Doi Number: 10.1007/s12603-011-0095-4
  • Journal Name: JOURNAL OF NUTRITION HEALTH & AGING
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.139-141
  • Keywords: Insulin resistance, rivastigmine, Alzheimer disease, elderly, GLUCOSE-METABOLISM, COGNITIVE FUNCTION, DIABETES-MELLITUS, ACETYLCHOLINESTERASE, BUTYRYLCHOLINESTERASE, INFLAMMATION, POPULATION, MODEL, RISK
  • Dokuz Eylül University Affiliated: Yes

Abstract

Insulin resistance (IR) may play a role in most pathogenic processes that promote the development of Late Onset Alzheimer Disease (LOAD). This study was designed to determine the interaction between inhibition of both butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) with rivastigmine and peripheral insulin resistance (IR) in LOAD.